Cargando…

Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era

Detalles Bibliográficos
Autores principales:	Zokufa, N., Lebelo, K., Hacking, D., Tabo, L., Runeyi, P., Malabi, N., Sibanda, S. B., Cassidy, T., Makanda, G., Norman, B., Khuzani, S., Furin, J., Jonker, C., Nkasana, B., Scott, V., Pfaff, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union Against Tuberculosis and Lung Disease 2021
Materias:	Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091909/ https://www.ncbi.nlm.nih.gov/pubmed/33977911 http://dx.doi.org/10.5588/ijtld.21.0077

Ejemplares similares

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
por: Mohr-Holland, E., et al.
Publicado: (2021)

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting
por: Cates, L., et al.
Publicado: (2021)

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022)

What Research Is Needed to Stop TB? Introducing the TB Research Movement
por: Lienhardt, Christian, et al.
Publicado: (2011)

Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19
por: Mohr-Holland, E., et al.
Publicado: (2021)

Current state of national TB laboratory networks in Europe: achievements and challenges
por: Klaos, K., et al.
Publicado: (2022)

Towards quality adolescent-friendly services in TB care
por: Laycock, K. M., et al.
Publicado: (2021)

Active case-finding for TB among incarcerated women in Peru
por: Puma, D., et al.
Publicado: (2023)

Sputum culture conversion definitions and analytic practices for multidrug-resistant TB
por: Rodriguez, C. A., et al.
Publicado: (2021)

XDR-TB in South Africa: No Time for Denial or Complacency
por: Singh, Jerome Amir, et al.
Publicado: (2007)

Costs of treating multidrug-resistant TB in California in 2022
por: Katrak, S., et al.
Publicado: (2023)

Criminal Justice Reform as HIV and TB Prevention in African Prisons
por: Todrys, Katherine W., et al.
Publicado: (2012)

Pediatric delamanid treatment for children with rifampicin-resistant TB
por: Tyeku, N., et al.
Publicado: (2022)

Confronting TB/HIV in the era of increasing anti-TB drug resistance
por: Chakaya, Jeremiah, et al.
Publicado: (2008)

Best practices for the care of pregnant people living with TB
por: Maugans, C., et al.
Publicado: (2023)

TB control in India in the COVID era
por: Behera, D.
Publicado: (2021)

Early mortality during rifampicin-resistant TB treatment
por: Mohr-Holland, E., et al.
Publicado: (2022)

Pediatric TB detection in the era of COVID-19
por: Golandaj, Javeed A.
Publicado: (2022)

TB Anywhere is TB Everywhere
por: Wortham, Jonathan M.
Publicado: (2018)

TB or not TB! That’s the question
por: Nugud, Ahmed, et al.
Publicado: (2019)

A very sneaky bug: perspectives of front-line clinicians on whole-genome sequencing for drug-resistant TB
por: Memani, B., et al.
Publicado: (2022)

The Era of Human-Induced Diseases
por: Chaber, Anne-Lise
Publicado: (2017)

Childhood TB in HIV ERA - in sub saharan africa
por: Anwar, MN
Publicado: (2015)

Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa
por: Seung, Kwonjune J., et al.
Publicado: (2009)

Addressing diabetes mellitus as part of the strategy for ending TB
por: Harries, Anthony D., et al.
Publicado: (2016)

Striking the Right Balance Determines TB or Not TB
por: BoseDasgupta, Somdeb, et al.
Publicado: (2014)

HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town
por: Kaplan, Richard, et al.
Publicado: (2018)

TB or not TB? Difficulties in the diagnosis of tuberculosis in HIV-negative immigrants to Germany
por: Singh, DD, et al.
Publicado: (2011)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

UNITE4TB: a new consortium for clinical drug and regimen development for TB
por: Boeree, M. J., et al.
Publicado: (2021)

Clinical standards for drug-susceptible TB in children and adolescents
por: Chiang, S. S., et al.
Publicado: (2023)

Cost of TB services: approach and summary findings of a multi-country study (Value TB)
por: Sweeney, S., et al.
Publicado: (2022)

Clinical standards for drug-susceptible pulmonary TB
por: Akkerman, O. W., et al.
Publicado: (2022)

Pneumocystis pneumonia in the COVID-19 pandemic era: similarities and challenges
por: Szydłowicz, Magdalena, et al.
Publicado: (2021)

D‐dimer testing in clinical practice in the era of COVID‐19
por: Auditeau, Claire, et al.
Publicado: (2022)

Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
por: Prasad, Rajendra, et al.
Publicado: (2022)

Should Drug Information Be an Integral Part of Health Care?
por: Hemminki, Elina, et al.
Publicado: (1996)

Investigating the response to COVID-19 and understanding severe TB cases: The 2022 Pulmonology TB series
por: Migliori, G.B., et al.
Publicado: (2022)

Challenges for China's medical education in the coming post-COVID-19 era
por: Shao, Li, et al.
Publicado: (2020)

What clinic closure reveals about care for drug-resistant TB: a qualitative study
por: Govender, Thiloshini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qgnuodcrrber14j832efj9q1lk